[HTML][HTML] Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing …
D Niewerth, GJL Kaspers, G Jansen… - Journal of hematology & …, 2016 - Springer
Background Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
[引用][C] Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
D Niewerth, GJL Kaspers… - JOURNAL OF …, 2016 - researchinformation.amsterdamumc …
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute
leukaemia patients receiving bortezomib-containing chemotherapy — Amsterdam UMC …
leukaemia patients receiving bortezomib-containing chemotherapy — Amsterdam UMC …
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
D Niewerth, GJL Kaspers, G Jansen… - … of hematology & …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
[HTML][HTML] Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing …
D Niewerth, GJL Kaspers, G Jansen… - … of Hematology & …, 2016 - ncbi.nlm.nih.gov
Background Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy.
D Niewerth, GJL Kaspers… - … of Hematology & …, 2016 - search.ebscohost.com
Background: Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
[HTML][HTML] Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing …
D Niewerth, GJL Kaspers, G Jansen… - … of Hematology & …, 2016 - search.proquest.com
Background Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
[PDF][PDF] Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
D Niewerth, GJL Kaspers, G Jansen, J van Meerloo… - 2016 - core.ac.uk
Background: Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
[引用][C] Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
D Niewerth, GJL Kaspers, G Jansen… - Journal of Hematology …, 2016 - cir.nii.ac.jp
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute
leukaemia patients receiving bortezomib-containing chemotherapy | CiNii Research CiNii 国立 …
leukaemia patients receiving bortezomib-containing chemotherapy | CiNii Research CiNii 国立 …
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
D Niewerth, GJL Kaspers, G Jansen, J van Meerloo… - tspace.library.utoronto.ca
Background Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
[PDF][PDF] Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
D Niewerth, GJL Kaspers, G Jansen, J van Meerloo… - 2016 - cyberleninka.org
Background: Drug combinations of the proteasome inhibitor bortezomib with cytotoxic
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …
chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric …